By Chris Bailey | Thursday 11 July 2019
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
A month or so ago, I noted that Reckitt Benckiser (RB.) was a 'lower £60s buy in anticipation of a share price beginning with a '7' plus some solid dividend wrap-around...and a call option on that full split potential'. The rationale for this was not just the company's range of top products (Vanish, Nurofen, Dettol, Durex, etc.) nor even just potential upcoming split or a recently announced management evolution which I think is overdue. It was also centred on the likely resolution of the company's legacy problems with its ex pharmaceutical unit Indivior (INDV)...
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.
Filed under:
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Time left: 03:58:15